![](/img/cover-not-exists.png)
Impact of pazopanib on docetaxel exposure: results of a phase I combination study with two different docetaxel schedules
Hamberg, P., Mathijssen, R. H. J., de Bruijn, P., Leonowens, C., van der Biessen, D., Eskens, F. A. L. M., Sleijfer, S., Verweij, J., de Jonge, M. J. A.Volume:
75
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-014-2655-x
Date:
February, 2015
File:
PDF, 389 KB
english, 2015